MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis
暂无分享,去创建一个
A. Noël | Agnès Noël | Nor Eddine Sounni | Alexandra Paye | Lorin Host | A. Paye | N. Sounni | L. Host | Alexandra Paye | Lorin Host
[1] Asif Ahmed,et al. VEGF Induces Tie2 Shedding via a Phosphoinositide 3-Kinase/Akt–Dependent Pathway to Modulate Tie2 Signaling , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[2] Kenji Nakamura,et al. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells , 2007, Journal of Cell Science.
[3] Amber N. Stratman,et al. Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. , 2009, Blood.
[4] Hyun-Jai Cho,et al. Cytokines and Matrix Metalloproteinases Progenitor Cells and Late Outgrowth Endothelial Cells: the Role of Angiogenic Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Ou , 2022 .
[5] Y. Sato. Activation of latent TGF-beta at the vascular wall--roles of endothelial cells and mural pericytes or smooth muscle cells. , 1995, Journal of atherosclerosis and thrombosis.
[6] P. Iversen,et al. Interstitial fluid: the overlooked component of the tumor microenvironment? , 2010, Fibrogenesis & tissue repair.
[7] Lynda F. Bonewald,et al. Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts , 2002, The Journal of Biological Chemistry.
[8] D. McDonald,et al. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. , 2003, The American journal of pathology.
[9] D. Azar,et al. MT1-MMP-Mediated Cleavage of Decorin in Corneal Angiogenesis , 2009, Journal of Vascular Research.
[10] Kristian Pietras,et al. High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.
[11] Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. , 2006, Diabetes.
[12] J. Foidart,et al. Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine Kinases* , 2004, Journal of Biological Chemistry.
[13] Asif Ahmed,et al. VEGF Induces Tie 2 Shedding via a Phosphoinositide 3-Kinase / Akt – Dependent Pathway to Modulate Tie 2 Signaling , 2007 .
[14] O. Féron. Targeting the tumor vascular compartment to improve conventional cancer therapy. , 2004, Trends in pharmacological sciences.
[15] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[16] J. Rundhaug,et al. Matrix metalloproteinases and angiogenesis , 2005, Journal of cellular and molecular medicine.
[17] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[18] J. Ward,et al. MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.
[19] Brian Seed,et al. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation , 2003, Nature Medicine.
[20] S. Rafii,et al. Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.
[21] A. Raza,et al. Pericytes and vessel maturation during tumor angiogenesis and metastasis , 2010, American journal of hematology.
[22] R. Iozzo,et al. BMP-1/Tolloid-like Metalloproteases Process Endorepellin, the Angiostatic C-terminal Fragment of Perlecan* , 2005, Journal of Biological Chemistry.
[23] M. Swartz,et al. Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. , 2006, Microvascular research.
[24] I. Bièche,et al. Thrombospondin-1 Is a Plasmatic Marker of Peripheral Arterial Disease That Modulates Endothelial Progenitor Cell Angiogenic Properties , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[25] J. Foidart,et al. Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. , 2003, Matrix biology : journal of the International Society for Matrix Biology.
[26] R. W. Rauser,et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] Holger Gerhardt,et al. Pericytes limit tumor cell metastasis. , 2006, The Journal of clinical investigation.
[28] A. Redig,et al. Rho-ROCK-Myosin Signaling Meditates Membrane Type 1 Matrix Metalloproteinase-induced Cellular Aggregation of Keratinocytes* , 2010, The Journal of Biological Chemistry.
[29] K. Sekiguchi,et al. Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin–integrin interactions using recombinant α3β1, α6β1, α7β1 and α6β4 integrins , 2006 .
[30] Carine Munaut,et al. Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. , 2006, Cancer research.
[31] D. Edwards,et al. Metalloproteinases and their inhibitors in angiogenesis , 2003, Expert Reviews in Molecular Medicine.
[32] S. Hibino,et al. Identification of an Active Site on the Laminin α5 Chain Globular Domain That Binds to CD44 and Inhibits Malignancy , 2004, Cancer Research.
[33] P. Courtoy,et al. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. , 2006, European journal of cancer.
[34] W. English,et al. MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src , 2010, Journal of Cell Science.
[35] Andrew J. Ewald,et al. Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.
[36] A. Davidoff,et al. Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. , 2002, Blood.
[37] Michael D Feldman,et al. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. , 2003, The American journal of pathology.
[38] A. Yayon,et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.
[39] R. Iozzo,et al. Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the α2β1-integrin receptor , 2007 .
[40] Gabriele Bergers,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during , 2000 .
[41] P. Iversen,et al. The Role of the Extracellular Matrix in Tissue Distribution of Macromolecules in Normal and Pathological Tissues: Potential Therapeutic Consequences , 2008, Microcirculation.
[42] R. Iozzo,et al. Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the alpha2beta1-integrin receptor. , 2007, Blood.
[43] Jingsong Xu,et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo , 2001, The Journal of cell biology.
[44] L. Liotta,et al. Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events , 1990, The Journal of cell biology.
[45] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[46] G. Ahn,et al. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. , 2008, Cancer cell.
[47] B. Hudson,et al. MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis. , 2009, Developmental cell.
[48] H. Kleinman,et al. Identification of redundant angiogenic sites in laminin α1 and γ1 chains , 2003 .
[49] Holger Gerhardt,et al. Pericytes: gatekeepers in tumour cell metastasis? , 2008, Journal of Molecular Medicine.
[50] S Eguchi,et al. Activation of MAPKs by Angiotensin II in Vascular Smooth Muscle Cells , 2001, The Journal of Biological Chemistry.
[51] A. Noël,et al. Matrix metalloproteinases at cancer tumor-host interface. , 2008, Seminars in cell & developmental biology.
[52] Bonnie F. Sloane,et al. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. , 2004, The American journal of pathology.
[53] D. Pode,et al. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. , 1999, The Journal of clinical investigation.
[54] K. Sekiguchi,et al. Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. , 2006, Matrix biology : journal of the International Society for Matrix Biology.
[55] M. Detmar,et al. The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. , 2002, The American journal of pathology.
[56] S. Paku. Current concepts of tumor-induced angiogenesis , 2008, Pathology & Oncology Research.
[57] R. Fridman,et al. Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration. , 2010, Cancer research.
[58] B R Johansson,et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.
[59] S. Weiss,et al. Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.
[60] S. Krane,et al. Stromal regulation of vessel stability by MMP14 and TGFβ , 2010, Disease Models & Mechanisms.
[61] L. Coussens,et al. Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.
[62] H. Kleinman,et al. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro , 1989, Cell.
[63] G. Davis,et al. Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression , 2008, Current opinion in hematology.
[64] I. Fidler,et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. , 2002, Journal of the National Cancer Institute.
[65] Ronald T Raines,et al. Collagen structure and stability. , 2009, Annual review of biochemistry.
[66] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[67] H. Kleinman,et al. Identification of laminin alpha1 and beta1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] D. Gingras,et al. Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase* , 2004, Journal of Biological Chemistry.
[69] H. Augustin,et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.
[70] C. Gilles,et al. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[71] Hiroshi Sato,et al. MT1-MMP promotes cell growth and ERK activation through c-Src and paxillin in three-dimensional collagen matrix. , 2010, Biochemical and biophysical research communications.
[72] L. Devy,et al. MTI-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression , 2002 .
[73] Alex Y Strongin,et al. Simultaneous visualization of protumorigenic Src and MT1-MMP activities with fluorescence resonance energy transfer. , 2010, Cancer research.
[74] P. Brooks,et al. Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracellular matrix epitope in laminin. , 2007, Cancer research.
[75] S. Weiss,et al. MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing , 2009, Journal of Cell Science.
[76] S. Weiss,et al. Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.
[77] S. Formenti,et al. Disruption of Endothelial Cell Interactions with the Novel HU177 Cryptic Collagen Epitope Inhibits Angiogenesis , 2007, Clinical Cancer Research.
[78] R. Kalluri. Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.
[79] S. Groshen,et al. Stromal Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblastoma by Promoting Pericyte Recruitment , 2004, Cancer Research.
[80] Richard Mayne,et al. Multiple Binding Sites in Collagen Type I for the Integrins α1β1 and α2β1 * , 2000, The Journal of Biological Chemistry.
[81] D. Gingras,et al. Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. , 2004, Blood.
[82] Sarah L Dallas,et al. Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. , 2002, The Journal of biological chemistry.
[83] M. Detmar,et al. The α1β1 and α2β1 Integrins Provide Critical Support for Vascular Endothelial Growth Factor Signaling, Endothelial Cell Migration, and Tumor Angiogenesis , 2002 .
[84] S. Germain,et al. Critical overexpression of thrombospondin 1 in chronic leg ischaemia , 2005, The Journal of pathology.
[85] C. López-Otín,et al. Membrane type-matrix metalloproteinases (MT-MMP). , 2003, Current topics in developmental biology.
[86] P. Quax,et al. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. , 2003, Blood.
[87] R. Iozzo. Basement membrane proteoglycans: from cellar to ceiling , 2005, Nature Reviews Molecular Cell Biology.
[88] A. Turner,et al. MT1-MMP association with membrane lipid rafts facilitates G-CSF--induced hematopoietic stem/progenitor cell mobilization. , 2010, Experimental hematology.
[89] I. Jo,et al. Coordinated regulation of angiopoietin-1 and vascular endothelial growth factor by arsenite in human brain microvascular pericytes: implications of arsenite-induced vascular dysfunction. , 2009, Toxicology.
[90] A. Strongin,et al. Timp‐2 binding with cellular MT1‐MMP stimulates invasion‐promoting MEK/ERK signaling in cancer cells , 2009, International journal of cancer.
[91] D. Hanahan,et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. , 2006, Genes & development.
[92] S. Dangi‐Garimella,et al. Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression , 2011, Oncogene.
[93] D. McDonald,et al. Cellular abnormalities of blood vessels as targets in cancer. , 2005, Current opinion in genetics & development.
[94] A. Nagler,et al. MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. , 2009, The Journal of clinical investigation.
[95] L. Orci,et al. Collagen matrix promotes reorganization of pancreatic endocrine cell monolayers into islet-like organoids , 1983, The Journal of cell biology.
[96] A. Verkman,et al. Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[97] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[98] A. A. Miles,et al. Vascular reactions to histamine, histamine‐liberator and leukotaxine in the skin of guinea‐pigs , 1952, The Journal of physiology.
[99] S. Belmadani,et al. Involvement of Metalloproteinases 2/9 in Epidermal Growth Factor Receptor Transactivation in Pressure-Induced Myogenic Tone in Mouse Mesenteric Resistance Arteries , 2004, Circulation.
[100] Y. Takeishi,et al. Involvement of membrane type 1‐matrix metalloproteinase (MT1‐MMP) in RAGE activation signaling pathways , 2011, Journal of cellular physiology.
[101] M. Bernardo,et al. MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer , 2008, Cancer and Metastasis Reviews.
[102] J. Keski‐Oja,et al. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. , 2008, Experimental cell research.
[103] B. Lévy,et al. Regulation of Matrix Metalloproteinase Activity in Ischemic Tissue by Interleukin-10: Role in Ischemia-Induced Angiogenesis , 2001, Circulation research.
[104] T. Fujii,et al. An Autocrine Linkage Between Matrix Metalloproteinase-14 and Tie-2 Via Ectodomain Shedding Modulates Angiopoietin-1–Dependent Function in Endothelial Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[105] R. Jaenisch,et al. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling , 1995, The Journal of cell biology.
[106] S. Weiss,et al. Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP–dependent and –independent Processes , 2002, The Journal of experimental medicine.
[107] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[108] R. Rich,et al. Multiple binding sites in collagen type I for the integrins alpha1beta1 and alpha2beta1. , 2000, The Journal of biological chemistry.
[109] C. Overall,et al. Characterization of the Distinct Collagen Binding, Helicase and Cleavage Mechanisms of Matrix Metalloproteinase 2 and 14 (Gelatinase A and MT1-MMP) , 2004, Journal of Biological Chemistry.
[110] H. Munshi,et al. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. , 2006, Cancer research.
[111] L. Devy,et al. MT1‐MMP expression promotes tumor growth and angiogenesis through an up‐regulation of vascular endothelial growth factor expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[112] R. Jain,et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.
[113] S. Rafii,et al. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.
[114] A. Strongin,et al. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. , 2002, Cancer research.
[115] E. Im,et al. Phospholipase Cγ Activation Drives Increased Production of Autotaxin in Endothelial Cells and Lysophosphatidic Acid-Dependent Regression , 2010, Molecular and Cellular Biology.
[116] Stephen J. Weiss,et al. MT1-MMP–dependent neovessel formation within the confines of the three-dimensional extracellular matrix , 2004, The Journal of cell biology.
[117] S. Dangi‐Garimella,et al. Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion* , 2011, The Journal of Biological Chemistry.
[118] M. Ratajczak,et al. Hyaluronic acid and thrombin upregulate MT1-MMP through PI3K and Rac-1 signaling and prime the homing-related responses of cord blood hematopoietic stem/progenitor cells. , 2011, Stem cells and development.
[119] E. Im,et al. New Insights Regarding Vessel Regression , 2006, Cell Cycle.
[120] H. Kleinman,et al. Identification of laminin α1 and β1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting , 1999 .
[121] H. Verspaget,et al. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. , 2010, Cancer research.
[122] N. Boudreau,et al. Extracellular matrix and integrin signalling: the shape of things to come. , 1999, The Biochemical journal.
[123] M. Hendrix,et al. Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma , 2003, Nature Reviews Cancer.
[124] I. Stamenkovic,et al. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. , 2002, Genes & development.
[125] H. Kleinman,et al. Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains. , 2003, Experimental cell research.
[126] C. López-Otín,et al. Emerging roles of proteases in tumour suppression , 2007, Nature Reviews Cancer.
[127] Y. Itoh,et al. Matrix metalloproteinases in cancer. , 2002, Essays in biochemistry.
[128] M. Klagsbrun,et al. Matrix Metalloproteinase-3 Releases Active Heparin-binding EGF-like Growth Factor by Cleavage at a Specific Juxtamembrane Site* , 1997, The Journal of Biological Chemistry.
[129] J. Foidart,et al. Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture , 2009, Journal of cellular and molecular medicine.
[130] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[131] S. Weiss,et al. An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature. , 2005, Genes & development.
[132] I. Weissman,et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth , 2008, Proceedings of the National Academy of Sciences.
[133] Y. Okada,et al. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. , 1997, The Biochemical journal.
[134] Y. Okada,et al. Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.